2006
DOI: 10.1111/j.1365-2133.2006.07155.x
|View full text |Cite
|
Sign up to set email alerts
|

Clindamycin and rifampicin combination therapy for hidradenitis suppurativa

Abstract: This small retrospective study indicates that combination therapy with clindamycin and rifampicin may be effective for HS. However, there is a need for a placebo-controlled trial.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

8
147
0
9

Year Published

2010
2010
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 192 publications
(170 citation statements)
references
References 14 publications
8
147
0
9
Order By: Relevance
“…In contrast to other chronic inflammatory skin diseases such as Ps, AI patients greatly suffer from bacterial persistence in the affected skin (2,5,7). In this study, we show for the first time, to our knowledge, that the AMP expression was significantly lower in AI lesions than in Ps lesions and even than in lesions from AD patients.…”
Section: Discussionmentioning
confidence: 50%
See 1 more Smart Citation
“…In contrast to other chronic inflammatory skin diseases such as Ps, AI patients greatly suffer from bacterial persistence in the affected skin (2,5,7). In this study, we show for the first time, to our knowledge, that the AMP expression was significantly lower in AI lesions than in Ps lesions and even than in lesions from AD patients.…”
Section: Discussionmentioning
confidence: 50%
“…Smoking, obesity, a respective genetic background, and hormonal factors may play a role in its development and/or course (5). The assumption of cutaneous bacterial persistence in affected skin as a crucial pathogenetic factor is in line with the fact that an antibiotic treatment was successful in AI patients (7).…”
mentioning
confidence: 88%
“…Chronic lesions, on the other hand, can be treated in a number of ways, including antibiotics 3,4,17,18 , hormones 19 and biologics 20,21 . However, non-surgical approaches provide only temporary improvement and relief.…”
Section: Discussionmentioning
confidence: 99%
“…formájában javasoltak. Három retrospektív (n=116) és egy prospektív (n=23) klinikai vizsgálat során clindamycin és rifampicin kombinációjával a betegek 80-85%-ánál észleltek klinikai választ (33)(34)(35)(36). A kezelések során jelentkező leggyakoribb mellékhatás (13-22%) gasztrointesztinális jellegű volt.…”
Section: áBraunclassified